Penn Medicine Provider
Gastroenterology
K. Rajender Reddy, MD
4.9
(228)
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
View 2 additional locations

About me

  • Director, Hepatology
  • Medical Director, Liver Transplantation
  • Founder's Professor in Hepatology
  • Professor of Medicine in Surgery

Education and training

  • Medical School: Osmania Medical College
  • Residency: Misericordia Hospital
  • Fellowship: University of Tennessee Medical Center
  • Fellowship: University of Miami Hospital and Clinic

What my patients think about me

Average Rating
4.9

228 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
he's very thorough
April 2025
5.0
5.0
great dr.
April 2025
5.0
5.0
it was very good
April 2025
5.0
5.0
personable, knowledgeable and patient.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Reddy is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Hammitt LL, Quinn D, Janczewska E, Pasquel FJ, Tytus R, Reddy KR, Abarca K, Khaertynova IM, Dagan R, Dawson R, McCauley J, Shekar T, Fu W, Pedley A, Sterling T, Tamms G, Musey L, Buchwald UK Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors. , Hum Vaccin Immunother. : 2023


Ferrante ND, Kallan MJ, Sukkestad S, Kodani M, Kitahata MM, Cachay ER, Bhattacharya D, Heath S, Napravnik S, Moore RD, Yendewa G, Mayer KH, Reddy KR, Hayden T, Kamili S, Martin JN, Kim HN, Lo Re V 3rd Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States , J Viral Hepat: 2023,879-888


Weinberg EM, Wong F, Vargas HE, Curry MP, Jamil K, Pappas SC, Sharma P, Reddy KR Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin , Liver Transpl. : 2023


Kulkarni AV, Lee J, Reddy KR Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI) , Expert Rev Gastroenterol Hepatol: 2023,1-13


Kim J, Newcomb CW, Carbonari DM, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, Chew K, Sterling TR, Hull M, Seaberg EC, Kirk GD, Coburn SB, Lang R, McGinnis KA, Gebo KA, Napravnik S, Kim HN, Lo Re V 3rd North American AIDS Cohort Collaboration on Research and Design of IeDEA. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design , PLoS One: 2023


Hirshorn RE, Schaubel DE, Abt PL, Reddy KR, Bittermann T. Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era , Liver Transpl. : 2023


Flamm S, Lawitz E, Borg B, Charlton M, Landis C, Reddy KR, Shiffman M, Alsina A, Chang C, Ravendhran N, Hernandez C, Hézode C, Scherbakovsky S, Mercier RC, Samuel D. Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. , Viruses: 2023


Rosenthal BE, Abt PL, Schaubel DE, Reddy KR, Bittermann T. Living Donor Liver Transplantation for Adults With High Model for End-stage Liver Disease Score: The US Experience. , Transplantation: 2023


Kulkarni AV, Reddy R, Arab JP, Sharma M, Shaik S, Iyengar S, Kumar N, Sabreena, Gupta R, Premkumar GV, Menon BP, Reddy DN, Rao PN, Reddy KR Early living donor liver transplantation for alcohol-associated hepatitis , Ann Hepatol.: 2023


Reddy KR, McLerran D, Marsh T, Parikh N, Roberts LR, Schwartz M, Nguyen MH, Befeler A, Page-Lester S, Tang R, Srivastava S, Rinaudo JA, Feng Z, Marrero JA. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: the Multi-center Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study. Gastroenterology , Gastroenterology: 2023


View all publications